Isturisa Treatment in Mild Autonomous Cortisol Secretion( MACS) — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Isturisa Treatment in Mild Autonomous Cortisol Secretion( MACS) — Stella

Home/Mild Autonomous Cortisol Secretion (MACS)/

View on ClinicalTrials.gov

Recruiting

Back to Mild Autonomous Cortisol Secretion (MACS) trials

Phase 4 — Post-approval study. The treatment has been approved, but researchers continue monitoring it in a large population over time.

Trial locations(1 site)

United States

Johns Hopkins University School of Medicine, Baltimore, Maryland

Key details

Phase

Post-approval study

Sponsor

Johns Hopkins University

Collaborators

Recordati Rare Diseases Inc

Enrollment target

~10 participants

Started

February 2026

Primary completion

December 2028

Age range

18 Years and older

Last updated March 2026

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.